RT @drdavidliew: Just so good to see PMR on the plenary stage at #ACR22, after #EULAR2022 too SAPHYR study: sarilumab a

Just so good to see PMR on the plenary stage at #ACR22, after #EULAR2022 too SAPHYR study: sarilumab allows for - a quicker steroid wean & less toxicity - but also far more disease remission, quicker symptom resolution, better quality of life Game-changing. ABST1676 @RheumNow https://t.co/ZVqlMNoniu https://t.co/Fv3VRZrKGe